|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maier H, Dietz A, Gewelke U, Seitz HK and
Heller WD: Tobacco- and alcohol-associated cancer risk of the upper
respiratory and digestive tract. Laryngorhinootologie. 69:505–511.
1990.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dal Maso L, Torelli N, Biancotto E, Di
Maso M, Gini A, Franchin G, Levi F, La Vecchia C, Serraino D and
Polesel J: Combined effect of tobacco smoking and alcohol drinking
in the risk of head and neck cancers: A re-analysis of case-control
studies using bi-dimensional spline models. Eur J Epidemiol.
31:385–393. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Mofty SK: Histopathologic risk factors
in oral and oropharyngeal squamous cell carcinoma variants: An
update with special reference to HPV-related carcinomas. Med Oral
Patol Oral Cir Bucal. 19:e377–e385. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Broccolo F, Ciccarese G, Rossi A, Anselmi
L, Drago F and Toniolo A: Human papillomavirus (HPV) and
Epstein-Barr virus (EBV) in keratinizing versus non- keratinizing
squamous cell carcinoma of the oropharynx. Infect Agent Cancer.
13:322018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ali J, Sabiha B, Jan HU, Haider SA, Khan
AA and Ali SS: Genetic etiology of oral cancer. Oral Oncol.
70:23–28. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hammarstedt L, Lindquist D, Dahlstrand H,
Romanitan M, Dahlgren LO, Joneberg J, Creson N, Lindholm J, Ye W,
Dalianis T and Munck-Wikland E: Human papillomavirus as a risk
factor for the increase in incidence of tonsillar cancer. Int J
Cancer. 119:2620–2623. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chaturvedi AK, Engels EA, Pfeiffer RM,
Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M,
Cozen W, et al: Human papillomavirus and rising oropharyngeal
cancer incidence in the United States. J Clin Oncol. 29:4294–4301.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hong AM, Grulich AE, Jones D, Lee CS,
Garland SM, Dobbins TA, Clark JR, Harnett GB, Milross CG, O'Brien
CJ and Rose BR: Squamous cell carcinoma of the oropharynx in
Australian males induced by human papillomavirus vaccine targets.
Vaccine. 28:3269–3272. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Erjala K, Pulkkinen J, Kulmala J and
Grenman R: Concomitant vinorelbine and radiation in head and neck
squamous cell carcinoma in vitro. Acta Oncol. 43:169–174. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Erjala K, Zhang N, Sundvall M, Kulmala J,
Elenius K and Grenman R: Concomitant chemoirradiation with
vinorelbine and gefitinib induces additive effect in head and neck
squamous cell carcinoma cell lines in vitro. Radiother Oncol.
85:138–145. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rivera F, Vega-Villegas ME, López-Brea M,
Isla D, Mayorga M, Galdós P, Rubio A, Del Valle A, García-Reija F,
García-Montesinos B, et al: Randomized phase II study of cisplatin
and 5-FU continuous infusion (PF) versus cisplatin, UFT and
vinorelbine (UFTVP) as induction chemotherapy in locally advanced
squamous cell head and neck cancer (LA-SCHNC). Cancer Chemother
Pharmacol. 62:253–261. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Larsen S, Serup-Hansen E, Andersen LJ,
Lindeløv B, McCulloch T, Adimi P and Bastholt L: A phase II study
using vinorelbine and continuous 5-fluorouracil in patients with
advanced head and neck cancer. Acta Oncol. 46:374–377. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koussis H, Scola A, Bergamo F, Tonello S,
Basso U, Karahontzitis P, Chiarion-Sileni V, Pasetto L, Ruol A,
Loreggian L, et al: Neoadjuvant carboplatin and vinorelbine
followed by chemoradiotherapy in locally advanced head and neck or
oesophageal squamous cell carcinoma: A phase II study in elderly
patients or patients with poor performance status. Anticancer Res.
28:1383–1388. 2008.PubMed/NCBI
|
|
15
|
Marioni G, Koussis H, Gaio E, Giacomelli
L, Bertolin A, D'Alessandro E, Scola A, Ottaviano G, de Filippis C,
Jirillo A, et al: MASPIN's prognostic role in patients with
advanced head and neck carcinoma treated with primary chemotherapy
(carboplatin plus vinorelbine) and radiotherapy: Preliminary
evidence. Acta Otolaryngol. 129:786–792. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Massa E, Dessi M, Gaspardini G, Saba F,
Cherchi V and Mantovani G: Phase II study of vinorelbine/cetuximab
in patients with recurrent/metastatic squamous cell carcinoma of
the head and neck progressing after at least two chemotherapy
regimens. Oral Oncol. 46:818–821. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barth C, Naveau L, Touboul E, Périé S,
Bamogho E, Haberer-Guillerm S, Schlienger M, Lacau St Guily J and
Huguet F: Efficacy and safety of vinorelbine in heavily pretreated
recurrent/metastatic head and neck squamous cell carcinoma
patients. Anticancer Drugs. 27:349–352. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Airoldi M, Garzaro M, Pedani F, Ostellino
O, Succo G, Riva G, Sensini M, Naqe N, Bellini E, Raimondo L and
Pecorari G: Cisplatin+vinorelbine treatment of recurrent or
metastatic salivary gland malignancies (RMSGM): A final report on
60 cases. Am J Clin Oncol. 40:86–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gregory RK and Smith IE: Vinorelbine-a
clinical review. Br J Cancer. 82:1907–1913. 2000.PubMed/NCBI
|
|
20
|
Wong J and Fang G: HURP controls spindle
dynamics to promote proper interkinetochore tension and efficient
kinetochore capture. J Cell Biol. 173:879–891. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koffa MD, Casanova CM, Santarella R,
Köcher T, Wilm M and Mattaj IW: HURP is part of a Ran-dependent
complex involved in spindle formation. Curr Biol. 16:743–754. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sillje HH, Nagel S, Körner R and Nigg EA:
HURP is a Ran-importin beta-regulated protein that stabilizes
kinetochore microtubules in the vicinity of chromosomes. Curr Biol.
16:731–742. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Santarella RA, Koffa MD, Tittmann P, Gross
H and Hoenger A: HURP wraps microtubule ends with an additional
tubulin sheet that has a novel conformation of tubulin. J Mol Biol.
365:1587–1595. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen J, Liu QJ, Wang D, Zhou XY, Xiong D,
Li HJ and Li CL: Hepatoma upregulated protein expression is
involved in the pathogenesis of human breast carcinogenesis. Oncol
Lett. 8:2543–2548. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liao W, Liu W, Yuan Q, Liu X, Ou Y, He S,
Yuan S, Qin L, Chen Q, Nong K, et al: Silencing of DLGAP5 by siRNA
significantly inhibits the proliferation and invasion of
hepatocellular carcinoma cells. PLoS One. 8:e807892013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Al-Khafaji ASK, Marcus MW, Davies MPA,
Risk JM, Shaw RJ, Field JK and Liloglou T: AURKA mRNA expression is
an independent predictor of poor prognosis in patients with
non-small cell lung cancer. Oncol Lett. 13:4463–4468. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Q, Chen Y, Feng H, Zhang B and Wang
H: Prognostic and predictive value of HURP in nonsmall cell lung
cancer. Oncol Rep. 39:1682–1692. 2018.PubMed/NCBI
|
|
28
|
Hassan M, El Khattouti A, Ejaeidi A, Ma T,
Day WA, Espinoza I, Vijayakumar S and Gomez CR: Elevated expression
of hepatoma up-regulated protein inhibits gamma-irradiation-induced
apoptosis of prostate cancer cells. J Cell Biochem. 117:1308–1318.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang YH, Tian X, Liu OS, Fang XD, Quan HZ,
Xie S, Gao S and Tang ZG: Gene profiling analysis for patients with
oral verrucous carcinoma and oral squamous cell carcinoma. Int J
Clin Exp Med. 7:1845–1852. 2014.PubMed/NCBI
|
|
30
|
Weinberger P, Ponny SR, Xu H, Bai S,
Smallridge R, Copland J and Sharma A: Cell cycle M-phase genes are
highly upregulated in anaplastic thyroid carcinoma. Thyroid.
27:236–252. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sato M, Vaughan MB, Girard L, Peyton M,
Lee W, Shames DS, Ramirez RD, Sunaga N, Gazdar AF, Shay JW and
Minna JD: Multiple oncogenic changes (K-RAS(V12), p53 knockdown,
mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer
a full malignant phenotype on human bronchial epithelial cells.
Cancer Res. 66:2116–2128. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schache AG, Liloglou T, Risk JM, Filia A,
Jones TM, Sheard J, Woolgar JA, Helliwell TR, Triantafyllou A,
Robinson M, et al: Evaluation of human papilloma virus diagnostic
testing in oropharyngeal squamous cell carcinoma: Sensitivity,
specificity, and prognostic discrimination. Clin Cancer Res.
17:6262–6271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schache AG, Liloglou T, Risk JM, Jones TM,
Ma XJ, Wang H, Bui S, Luo Y, Sloan P, Shaw RJ and Robinson M:
Validation of a novel diagnostic standard in HPV-positive
oropharyngeal squamous cell carcinoma. Br J Cancer. 108:1332–1339.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shi YX, Yin JY, Shen Y, Zhang W, Zhou HH
and Liu ZQ: Genome-scale analysis identifies NEK2, DLGAP5 and ECT2
as promising diagnostic and prognostic biomarkers in human lung
cancer. Sci Rep. 7:80722017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schache AG, Powell NG, Cuschieri KS,
Robinson M, Leary S, Mehanna H, Rapozo D, Long A, Cubie H, Junor E,
et al: HPV-related oropharynx cancer in the United Kingdom: An
evolution in the understanding of disease etiology. Cancer Res.
76:6598–6606. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bai Y, Cui X, Gao D, Wang Y, Wang B and
Wang W: Golgi integral membrane protein 4 manipulates cellular
proliferation, apoptosis, and cell cycle in human head and neck
cancer. Biosci Rep. 38:BSR201804542018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu M, Qiu YL, Jin T, Zhou Y, Mao ZY and
Zhang YJ: Meta-analysis of microarray datasets identify several
chromosome segregation-related cancer/testis genes potentially
contributing to anaplastic thyroid carcinoma. PeerJ. 6:e58222018.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schuler PJ, Trellakis S, Greve J, Bas M,
Bergmann C, Bölke E, Lehnerdt G, Mattheis S, Albers AE, Brandau S,
et al: In vitro chemosensitivity of head and neck cancer cell
lines. Eur J Med Res. 15:337–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hong MH, Kim CG, Koh YW, Choi EC, Kim J,
Yoon SO, Kim HR and Cho BC: Efficacy and safety of vinorelbine plus
cisplatin chemotherapy for patients with recurrent and/or
metastatic salivary gland cancer of the head and neck. Head Neck.
40:55–62. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rivera F, Vega-Villegas ME, López-Brea MF,
García-Castaño A, de Juan A, Ramos FJ, Collado A, Galdós P, Rubio
A, del Valle A, et al: Long term results of a phase II trial of
induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and
cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and
carboplatin (RT/UFTJ) in non-resectable locally advanced (stage
IV-B) squamous cell head and neck carcinoma and peripheral blood
stem cell support (PBSCS) with febrile neutropenia. Clin Transl
Oncol. 9:40–47. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pan JH, Han JX, Wu JM, Sheng LJ and Huang
HN: CYP450 polymorphisms predict clinic outcomes to
vinorelbine-based chemotherapy in patients with non-small-cell lung
cancer. Acta Oncol. 46:361–366. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pan JH, Han JX, Wu JM, Sheng LJ, Huang HN
and Yu QZ: MDR1 single nucleotide polymorphisms predict response to
vinorelbine-based chemotherapy in patients with non-small cell lung
cancer. Respiration. 75:380–385. 2008. View Article : Google Scholar : PubMed/NCBI
|
